Daily Stock List
ATC Venture Group, Inc. (ATC)
Energy and Capital reported recently on ATC Venture Group, Inc. (ATC), First Penny Picks, OTCPicks, Penny Stock Rumble, smartOTC, Streetwise Reports did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Minnetonka, Minnesota, ATC Venture Group, Inc. is the parent company to Simonsen Iron Works, Inc. Simonsen Iron Works is an Iowa-based fabricator, powder coat painter, and assembler of metal-based products. ATC previously owned Cycle Country Accessories that for over 30 years was the industry-leading designer, manufacturer and marketer of snowplows and other accessories for the ATV/UTV Powersports industry. The Company formerly went by the name Cycle Country Accessories Corp. They changed their name to ATC Venture Group, Inc. in January 2012.
ATC Venture Group, through their subsidiary, engages in the design, manufacture, and assembly of an assortment of parts for original equipment manufacturers (OEMs) and other customers. ATC Venture Group entered into an asset purchase agreement this year with K-W Manufacturing Co. (KW), a South Dakota-based manufacturer of patented snowplows, dozer blades, rock pickers, and other attachments for the skid steer loader market.
The Company agreed to purchase from KW certain of their assets, including equipment, contracts and associated goodwill in consideration for an aggregate purchase price of $500,000 and a royalty agreement of 5 percent of sales of the KW product line for each of the next five years. KW has been a leader for over 30 years in the design, manufacturing and marketing of their products. KW has been the leading supplier to almost all of the OEMs of skid steer loaders in North America.
In November, ATC Venture Group announced that they settled their lawsuit against Kolpin Outdoors, Inc. of Fox Lake, Wisconsin and their owners, FCF Partners LP of Milwaukee, Wisconsin, the purchaser of their Cycle Country Accessories product line. ATC filed suit in U.S. District Court to enforce their agreement with Kolpin Outdoors and FCF Partners after Kolpin failed to make payments to the Company under the Asset Purchase Agreement between the Company and Kolpin Outdoors, and FCF Partners refused to pay on their limited guaranty of those payments.
Effective October 26, 2012, Chief Magistrate Judge Boylan of the United States District Court for the State of Minnesota resolved certain disagreements between the parties concerning a written settlement agreement. The Judge ordered that the settlement that the parties had agreed to in Court on September 13, 2012 is binding and fully enforceable as provided in the written settlement agreement attached to the Court's order.
ATC Venture Group, Inc. (ATC), closed Tuesday at $0.1201, down 14.21%, on 3,300 volume with 10 trades. The average volume for the last 60 days is 5,694 and the stock's 52-week low/high is $0.0801/$1.00.
Bebida Beverage Co. (BBDA)
WallStreetBeats reported last week on Bebida Beverage Co. (BBDA), Bull in Advantage, Stock Analyzer, AimHighProfits, Greenbackers, Mina Mar Marketing Group did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.
Based in Statesville, North Carolina, Bebida Beverage Co. is a developer, manufacturer and marketer of liquid relaxation products. These include KOMA Unwind "Liquid Relaxation" ™, KOMA Unwind Sugar-free "Liquid Relaxation" ™ and KOMA Unwind "Liquid Relaxation" Shot™. Additionally, they include Potencia Energy, Potencia "BLAST" energy shot, Relax 5 shots and Piranha Water. Bebida Beverage lists on the OTC Markets – Pink Current Information.
The Company's KOMA Unwind is a multi-berry flavor lightly carbonated beverage enhanced with the dietary supplements of Melatonin, Milk Thistle, Rose Hips and Valarium root. Bebida offers this in regular and sugar free versions using Splenda as its sweetener. Their RELAX 5 2 oz. shots have a special blend of supplements.
Their Potencia is an energy drink that combines exotic natural flavors such as Tamarind with special ingredients. The Potencia energy drink is the very first energy drink known, made of the very popular Tamarind fruit. Distillation, de-ionization, reverse osmosis, or other suitable processes have produced Bebida Beverage's Piranha Purified Water.
In October, Bebida announced the opening of their new wholly owned subsidiary in the New York metropolitan area for the distribution of their products, and other products. The Company added the subsidiary will also sell their own Piranha Water and Potencia Energy brands.
Today, Bebida announced that the first European online store for sales of KOMA UNWIND is now open in Belgium. Countries served will include Belgium, Luxembourg, Netherlands, Germany, Italy, Great Britain, Norway, Spain, Portugal, Czech Republic, Greece, Switzerland, Austria, Turkey, Hungary, Poland, Finland, Sweden, and France.
Furthermore, today, Bebida Beverage announced that Coca Cola Bottling of Hancock, Michigan will offer KOMA UNWIND to their 800 DSD locations in the upper peninsula of Michigan. This partnership will include service to Keweenaw, Ontonagon, Houghton and Baraga counties in the Upper Peninsula of Michigan. Sherwood Foods is the Master Distributor in Michigan. Coca Cola Bottling will pull their supply requirements for KOMA UNWIND from Sherwood Foods.
Bebida Beverage Co. (BBDA), closed Tuesday's trading at $0.006, up 66.67%, on 149,299,092 volume with 675 trades. The average volume for the last 60 days is 20,063,901 and the stock's 52-week low/high is $0.0003/$0.0199.
Myriad Interactive Media, Inc. (MYRY)
OTCPicks reported recently on Myriad Interactive Media, Inc. (MYRY), Investor News Source, Penny Dreamers, Stock Twiter did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Myriad Interactive Media, Inc. is an interactive marketing and development firm. They design and develop customized marketing plans, social media marketing campaigns, pay per click (PPC), and search engine marketing. They also develop in house web and mobile applications. Myriad Interactive Media is based in Toronto, Ontario.
Pertaining to Social Media Marketing, the Company can build and structure marketing campaigns for Facebook, Twitter and Google Plus. They can perform a comprehensive analysis on the customer's target audience and utilize best practices in creating and launching social media campaigns. The most common campaigns Myriad plans to conduct will be for increasing brand recognition and driving user engagement.
Concerning Search Engine Marketing, Myriad is a recognized search firm with Google. The Company structures high quality adwords campaigns. For Website Development, they have a separate team of four consultants working on website development and web architecture. Their team can build complete web solutions from scratch; this includes graphic design and CSS coding.
For Application Development, Myriad is currently developing an interactive mobile application for the Apple iPhone and Apple iPad devices. The Company is registered as an Apple developer. They plan on launching this application under their Apple SDK. In addition, they will be introducing mobile development for the Google Android platform.
The Company has developed an in-house daily deal aggregator web application for the Brazilian market called CuponZilla.com.br. The platform is a sophisticated application that tracks all of the daily deals in Brazil offered by daily deal sites such as Groupon, PeixeUrbano and Groupalia. They track these deals by using application programming interface (API) and parsing technology.
Daily deals are run through the Company's databases. They are presented on their website to subscribers that are using their deal filtering technology to source daily deals of particular interest. Myriad’s platform aggregates thousands of deals from every credible daily deal website in Brazil. The Company receives referral commissions on daily deal sites that offer API access and commission services. For those sites that do not provide API's, they do not receive any commissions. CuponZilla.com.br is currently fully operational.
In mid-October, Myriad Interactive Media Chief Executive Officer Mr. Derek Ivany announced that the Company acquired a distinctive social media technology called Mingle from a technology firm headquartered in Toronto, Ontario. This social media application combines social media networks such as Facebook, Twitter, Google+ and YouTube into one place. Additionally, the application allows users to connect photo sharing sites like Flickr and Facebook Albums, high definition video from Vimeo, and quality blogging & SEO solutions powered by Wordpress. Myriad's plan is to assimilate Pinterest and some other social sharing solutions in the near future.
Myriad Interactive Media, Inc. (MYRY), closed at $0.025, down 7.41%, on 40,000 volume with 3 trades. The average volume for the last 60 days is 349,757 and the stock's 52-week low/high is $0.0081/$0.17.
California Gold Corp. (CLGL)
StockLockandLoad, StockBomb.com, StockRockandRoll, and PennyStockLocks.com reported earlier on California Gold Corp. (CLGL), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.
California Gold Corp. is an exploration stage mining company whose focus is the identification, acquisition, and development of rare and precious metals mining properties in the Americas. Their primary concentration is on the exploration and development of the La Viuda Concessions south of Moctezuma, Sonora, Mexico. The Company believes that deposits of tellurium, gold and silver may exist in economically minable quantities in these concessions. California Gold is based in La Cañada, California.
California Gold is exploring and has a right to acquire up to an 80 percent interest in Mexivada Mining Corp.'s La Viuda and La Viuda-1 properties. Together, they comprise their AuroTellurio tellurium-gold-silver property south of the city of Moctezuma. This property surrounds a significant tellurium mine now undergoing development by First Solar, Inc.
California Gold can earn their 80 percent interest in the AuroTellurio project over a 48-month period through making structured payments of Mexivada of cash and shares. The Company is investing up to US$3 million on the exploration of the project in four tranches of at least US$750,000 annually. To date, the Company has already earned their first 20 percent interest in the AuroTellurio Project.
The AuroTellurio project consists of 12,653 acres (51 sq. km.). It surrounds the prior-producing La Bambolla tellurium and gold mine now in active development by First Solar. First Solar's panels require significant tellurium in their manufacturing.
This past October, California Gold announced that they completed the majority of their planned 2011-2012 exploration program at their AuroTellurio project. The Company is currently planning a drilling program as a logical follow up to the exploration results generated so far.
The exploration program that began early in 2011 resulted in the delineation of two target areas in California Gold's mining concessions. These are Target 1 (aka the La Bambolla Extension), and Target 2 (aka the Deep-Seated Intrusive area).
California Gold Corp. (CLGL), closed Tuesday's trading session at $0.008, up 14.29%, on 120,500 volume with 5 trades. The average volume for the last 60 days is 105,283 and the stock's 52-week low/high is $0.0014/$0.12.
Cover-All Technologies, Inc. (COVR)
Stockhouse reported earlier on Cover-All Technologies, Inc. (COVR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Cover-All Technologies, Inc. provides distinctive, cost-effective business-focused solutions to the property and casualty insurance industry. The Company's customers include insurance companies, agents, brokers and managing general agents (MGAs). Cover-All Technologies was the first to deliver PC-based commercial insurance rating and policy issuance software. The Company has their headquarters in Morristown, New Jersey.
Currently, Cover-All Technologies is creating new and innovative insurance solutions that leverage the latest technologies. The design of the Company's proprietary technology solutions and services are to enable their customers to introduce new products fast, expand their distribution channels, reduce costs, as well as improve service to their customers.
The Company's Platforms include Cover-All® Policy, Cover-All® Test Studio, Cover-All® Business Intelligence, and BlueWave Claims. Cover-All® Policy is a 100 percent web-based P&C Policy Administration system. It provides real-time management for carriers and agencies via management of the full policy lifecycle. Cover-All® Test Studio provides P&C insurance companies the flexibility to quickly institute and adopt product updates and changes while still being assured of the highest quality.
Cover-All® Business Intelligence reveals insights for business, power, and executive P&C users by way of pre-built measures, dimensions and KPIs with flexibility for configuration and "drill down and through" capabilities. BlueWave Claims is a 100 percent web-based claim management solution; claims professionals built it specifically for the P&C insurance industry. BlueWave Claims handles the full lifecycle of a claim – from first notice of loss to adjustment and resolution.
Last week, Cover-All Technologies announced that Mr. John Roblin, Chairman of the Board of Directors and Chief Executive Officer of the Company, would present at the LD Micro Fifth Annual Conference at 5 p.m. (PST), Track 3, on December 5, 2012. The conference will take place December 5-6, 2012 at the Luxe Sunset Bel Air, 11461 Sunset Boulevard, Los Angeles, California. Cover-All management will be available during the day on December 5 for one-on-one meetings. LD MICRO is a by-invitation only newsletter firm that concentrates on finding undervalued companies in the micro-cap space.
Cover-All Technologies, Inc. (COVR), closed Tuesday's trading session at $1.08, even for the day, on 10,600 volume with 8 trades. The average volume for the last 60 days is 8,254 and the stock's 52-week low/high is $1.05/$2.40.
ERF Wireless, Inc. (ERFB)
FeedBlitz and Pumps and Dumps reported earlier on ERF Wireless, Inc. (ERFB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
ERF Wireless, Inc. is a leading provider of enterprise-class wireless and broadband products and services. The Company is the parent company of Energy Broadband, Inc., ERF Enterprise Network Services, ERF Wireless Bundled Services, ERF Wireless Messaging Services, as well as ERF Network Operations. ERF Wireless has their corporate headquarters in League City, Texas. The Company's shares trade on the OTC Bulletin Board.
ERF Wireless specializes in providing wireless and broadband product and service solutions to enterprise, commercial and residential clients on a regional, national and global basis. The Company is a "Critical Infrastructure Communications Service Company". They provide high quality broadband services and basic communications services to residential, commercial, oil and gas, banking, healthcare and educational customers in areas that are traditionally unable to receive these services.
In addition, ERF Wireless is a complete solutions provider to other enterprise customers. They provide these customers with a broad spectrum of communications services. These services include high-speed broadband and Voice over Internet Protocol (VoIP) telephone and facsimile service.
The Company's Energy Broadband Division provides an innovative wireless broadband product and service offering to major oilfield producers and service providers. This includes secure, cost-effective data transmission to and from drilling rigs and production wells across North America. The Enterprise Network Services Division provides banks and financial institutions with secure, next generation data connectivity. This division also provides the turnkey design and implementation of secure wireless broadband networks for enterprise-class applications.
The Wireless Bundled Services Division provides wireless broadband Internet connectivity, VoIP telephone service and several other traditional ISP services. The Wireless Messaging Services Division manufactures and supplies high-power wireless infrastructure equipment to the paging and mobile industry. This division is additionally a reseller for Vehiclepath™ GPS Fleet and Asset Tracking products. The Network Operations Division provides the overall day-to-day maintenance and 24/7 monitoring of all wireless broadband networks that ERF Wireless constructs, acquires, maintains and administers. In addition, this division provides project-level wireless broadband system design, construction and implementation.
Today, ERF Wireless announced that Mr. Manny Carter recently joined the Company's Board of Directors. Mr. Carter has achieved a distinguished career in the oil and gas industry. He has served as a member of numerous corporate and Joint Venture boards throughout his career.
ERF Wireless, Inc. (ERFB), closed Tuesday's session at $0.819, down 2.50%, on 6,400 volume with 11 trades. The average volume for the last 60 days is 16,458 and the stock's 52-week low/high is $0.52/$3.03.
Falcon Oil & Gas Ltd. (FOLGF)
PennyInvest, HotOTC, MadPennyStocks, BullRally, StockRich, StockEgg, PennyStockVille, and CoolPennyStocks reported previously on Falcon Oil & Gas Ltd. (FOLGF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Dublin, Ireland, Falcon Oil & Gas Ltd. is an energy company focusing on acquiring, exploring and developing large acreage positions of unconventional and conventional oil and gas resources. The Company holds close to 15 million acres in three major exploration projects in Hungary, Australia, and South Africa. Falcon Oil & Gas also has an office in Budapest, Hungary. The Company lists on the OTC Pink Current Information and on the TSX Venture Exchange under the symbol FO.V.
Falcon Oil & Gas concentrates on areas in politically and economically stable countries characterized by a high regional demand for energy with existing infrastructure. This allows for rapid delivery of oil and gas to market.
In Hungary, the Company has 245,775 acres in the Mako Trough, Central Pannonian Basin. A 35-year Production License was granted on May 21, 2007. Falcon holds 100 percent interest in the acreage in a production license. Falcon's 100 percent subsidiary TXM Oil And Gas Exploration Ltd. holds and operates the license.
In the Beetaloo Basin, Australia, the Company has 7,000,000 acres onshore covering almost the entire Basin. Four Exploration Permits were granted in 2005 and 2006. The Company has a Joint Venture with Hess to acquire $55MM seismic and an option to drill 5 wells (Falcon 100 percent carried).
Falcon Oil & Gas Australia Ltd. is the majority owned subsidiary of Falcon Oil & Gas. Falcon Australia is a public, unlisted oil and gas company. They engage in the exploration and development of premier conventional and unconventional resources in the Beetaloo Basin, Northern Territory.
Falcon Oil & Gas has 7,500,000 acres onshore Karoo Basin, South Africa. The Karoo Basin reaches 600,000 sq. km. in central and southern South Africa and contains thick, organic rich shales such as the Permian Whitehill Formation. A Technical Cooperation Permit was granted in 2009, with an Exploration License pending. In August 2010, Falcon submitted an application for the exploration license.
Falcon Oil & Gas Ltd. (FOLGF), closed Tuesday's trading session at $0.194, up 2.11%, on 58,815 volume with 10 trades. The average volume for the last 60 days is 209,934 and the stock's 52-week low/high is $0.08/$0.241.
B Green Innovations, Inc. (BGNN)
OTCPicks and Wallstreetlivechat reported last week on B Green Innovations, Inc. (BGNN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
B Green Innovations, Inc.'s goal is to create a "Green" company for the development of solutions to eliminate waste from the world's environment. The Company's commitment is to focus on acquiring and identifying promising technologies that address environmental issues. The first technology will be used to create new products from recycled tire rubber. B Green Innovations has their headquarters in Matawan, New Jersey.
The Company has their EcoPod™ and VibeAway™ products. These are made from recycled tire rubber. EcoPod™ and VibeAway™ are 100 percent recycled rubber-based products; they can be used as support pads under any units that vibrate and make noise. These include washing machines, dryers, compressors, commercial condensers, and many other units that advantageously benefit from sound and vibration control.
The Company also offers biodegradable plastic garbage, compactor & pet bags. They will be offering degradable\biodegradable bags ASTM 5338 Standard, containing the new technology Renatura™. Plastic packaging products containing Renatura™ will degrade and biodegrade into Co2, H2O and compost (bio-waste) in the presence of oxygen. They will disintegrate to reduce unsightly plastic litter that pollutes landscapes and waterways and harms wildlife.
In landfills, plastic containing Renatura™ disappears expanding the landfill usage and life span. In addition, plastic packaging products containing Renatura™ will fragment. This allows organic matter enclosed to be consumed by anaerobic bacteria.
Moreover, B Green Innovations also supports interactive voice response software, designed to read information from and write information to databases, and to query databases and return information. Their IVR Interactive Voice Response System allows development of custom applications in a visual atmosphere. It commands Drag and Drop to execute an application. Additionally, it can read and write to the most popular databases, including Microsoft Access, SQL, ODBC, Microsoft Fox Pro, dBase, Microsoft Excel, Paradox, Btrieve, and simple text files.
B Green Innovations total sales increased $13,006 (20.3 percent) and $93,288 (54.4 percent) for the three and nine months ended September 30, 2012 to $77,169 and $264,815, respectively. This is in comparison to $64,163 and $171,527 for the same periods in the prior year. The net loss for the quarter ended September 30, 2012 was $112,566, compared to a net loss of $54,727 for the quarter ended September 30, 2011. The net loss for the nine months ended September 30, 2012 was $239,454, compared to a net loss of $237,698 for the nine months ended September 30, 2011.
B Green Innovations, Inc. (BGNN), closed Tuesday's trading session at $0.0005, up 25.00%, on 2,283,400 volume with 8 trades. The average volume for the last 60 days is 3,261,452 and the stock's 52-week low/high is $0.0002/$0.0014.
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.25, up 19.05%, on 642,540 volume with 116 trades. The stock’s average daily volume over the past 60 days is 117,934, and its 52-week low/high is $0.161/$0.68.
International Stem Cell Corp. reported that its Exec. VP will attend and present at the Fifth Annual LD Micro Conference this December 6, at the Luxe Hotel Sunset Boulevard in Los Angeles, California. The LD Micro Conference is a two-day event with some 200 institutions focused on small and micro-cap stocks slated to show up this year, all organized and brought to the community by internet-based newsletter LD Micro, which is known for helping savvy investors dig for the hidden gems in this space.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corp to Participate in Fifth Annual LD Micro Conference
International Stem Cell Corporation Announces Significant Progress Towards Clinical Development
International Stem Cell Corp Subsidiary Lifeline Skin Care Announces Latest Product Launch
Loans4Less.com, Inc. (LFLS)
The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.0615, up 48.19%, on 25,567 volume with 1 trade. The stock’s average daily volume over the past 60 days is 11,012, and its 52-week low/high is $0.01/$0.51.
Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.
Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.
The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.
Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulting on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer
Loans4Less.com, Inc. Company Blog
Loans4Less.com, Inc. News:
Loans4Less.com, Inc. Reports Financial Results for the Third Quarter of 2012
Loans4Less.com Provides Preliminary Financial Results for the Third Quarter of 2012
Loans4Less.com, Inc. New Audio Interview With Chairman and CEO Steven M. Hershman
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.713, up 1.86%, on 1,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 1,266, and its 52-week low/high is $0.06/$3.15.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
VistaGen's lead drug candidate, AV-101, is in Phase Ib development in the U.S. for treatment of neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system.
Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen Therapeutics Becomes Member of Centre for Commercialization of Regenerative Medicine Consortium
VistaGen Therapeutics Enhances Predictive Liver Toxicology and Drug Metabolism Bioassay System -- LiverSafe 3D™
VistaGen Therapeutics and Duke University Announce Heart Tissue Engineering Progress at American Heart Association 2012 Scientific Sessions
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $9.09, off by 0.11%, on 15,143 volume with 2 trades. The stock’s average daily volume over the past 47 days is 46,232, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
TNI BioTech Inc., and Hubei Qianjiang Pharmaceuticals Co., Ltd., Announce Venture Partnership for the Development of New Drug for Cancer Therapies
Dr. Henry "Skip" Lenz, Pharm.D, Joins TNI BioTech, Inc., as Quality Control Officer
International Stem Cell Corp., a California-based biotechnology company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, announced that its Executive Vice President will be attending and presenting at the Fifth Annual LD Micro Conference this week at the Luxe Hotel Sunset Boulevard in Los Angeles, California.
LD Micro Conference Presentation Details
Date: Thursday, December 6, 2012
Time: 12:00 pm PST
Location: Luxe Hotel Sunset Boulevard, Los Angeles, California
Investors who wish to attend the conference or schedule a meeting with ISCO’s management team should contact the conference organizers. To register for the event, call 408-457-1042 or e-mail firstname.lastname@example.org. Mark McPartland with MZ Group is accepting meeting requests on behalf of ISCO management via email email@example.com or phone 212-301-7130.
LD Micro is an internet-based newsletter that provides information on selected public companies to self-directed investors. It is anticipated that the two-day LD Micro Conference will be attended by more than 200 institutions focused on micro-cap and small-cap stocks. Last year, a record 580 people attended. For more information, please visit www.ldmicro.com.
The investor presentation to be given at the conference will be available on the investor relations section of ISCO’s Web site atwww.internationalstemcell.com.
Liberator is one of the nation’s foremost innovators of sexual health and wellness products, including furniture, apparel, bath and bedding items, and other intimacy-enhancing products. Based in Atlanta, Georgia, the company has broken the stereotype of companies in their industry, and has become, in the company’s own words, the “thought leader” of the market. Their unconventional approach has helped bring them, and the concept of sexual health and wellness, into the mainstream marketplace, with write-ups in the New York Times, and product appearances in Hollywood movies.
Unlike other companies in their industry, manufacturers and retailers who do the bulk of their business with China, Liberator has focused on carefully controlled product quality, with their design, manufacturing, logistics, and marketing vertically integrated in the same office and factory complex. By so doing, the company maintains superior quality control while continually giving back to the community. Their 140,000 square foot headquarters near Atlanta has offices, production facilities, and a distribution center with 15 tractor-trailer docks, and includes offices housing all in-house design, advertising, sales, and customer service operations. Liberator seeks out the best and brightest artists, craftspeople, and advertisers, providing both the positive and creative work environment and the financial incentive for all employees to contribute their best to the future of the company.
The company is also constantly innovating new ways to be a clean and green manufacturing company, emphasizing the three environmental R’s of Reduce, Reuse, and Recycle. For example, rather than simply discarding material left over from their foam contouring operation, they recycle and reuse that byproduct in the manufacture of other items. In the process, they reduce the energy used to manufacture new material and save space in already-overcrowded landfills. Their emphasis on single-location vertical integration also means less transport of materials, greatly reducing their carbon footprint.
In short, Liberator has gone its own path, differentiating itself in its industry, and growing rapidly in revenue.
For additional information on the company, visit www.Liberator.com
Biostar Pharmaceuticals, a PRC-based manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions in China, today announced that the company, on November 26, 2012, signed another one-year agreement with Xijing Military Hospital valued at approximately $8 million. The agreement requires that Biostar manufacture and supply Xijing Military Hospital with 16 new drugs used to treat an array of diseases such as pharyngitis, nasopharynx, gastroenteropathy, nephropathy, asthma, hyperplasia of mammary glands, dermatosis, gynecological diseases, etc.
The material terms of this agreement are comparable to the previous two one-year agreements Biostar signed with the same hospital back in September and October 2012, valued at $3.6 million and $3.0 million, respectively. The addition of this new agreement brings Biostar’s sum to 24 drugs which the company currently manufactures for Xijing Military Hospital (10 granules, 13 capsules, and one powder drug) totaling a combined worth of $14.6 million.
“We are pleased to have signed another drug manufacturing contract with Xijing Military Hospital as we continue to expand our drug portfolio with high quality products that are manufactured specifically for the needs of this hospital,” said Ronghua Wang, Biostar’s Chief Executive Officer and Chairman. “The signing of these agreements is a result of our hard work to quickly complete experimental tests, trial production, and pass manufacturing technology and quality inspections. These types of contracts have the potential to generate substantial revenues, have very low sales expenses and a much shorter sales cycle.”
Mr. Wang commented further, stating, “These agreements mark the initial step of our strategic partnership with The Fourth Military Medical University (‘FMMU’), one of China’s most prestigious military medical universities and research centers. As previously announced, we are working to become a strategic partner of FMMU in the fields of research and product development and also to become a production base for manufacturing drugs specifically for the needs of China’s military.”
For more information on Biostar Pharmaceuticals, visitwww.biostarpharmaceuticals.com
Crossroads Systems, one of the world’s top providers of robust data security and archiving solutions, reported today that Illinois-based financial holding powerhouse, Foresight Financial Group, Inc. ($891M in assets), is one of the largest ever to employ the company’s SPHiNX™, a data protection appliance designed to shield corporate, remote office, and data center’s from the threat posed to their vital information by disasters and similar loss scenarios.
CRDS has built up a track record of providing mid-range server/open system environment solutions like the one announced today, which screams competency to potential clients. Little wonder that a big dog like Foresight, which has 12 offices just in Winnebago and Stephenson counties (largest market share of deposits of any financial institution in the latter), has engaged the company for supporting their data centralization scheme, which serves a network of five of their community banks. Foresight’s centralized hub approach allows for a very cost effective means of assembling the infrastructure required by these banks to both maintain sensitive data and comply with FFIEC regulations.
This is a huge leap forward for Foresight’s antiquated backup methodology, which previously employed an IBM LTO-4 library and deployed replication handler, doing away with the fuss of time consuming physical library data retrieval. What used to take an entire day, and even then was not 100% accurate, is now resolved speedily via a virtualized environment that has round-the-clock uptime and allows for real-time access to backup data.
Senior Product Manager for CRDS, Glenn Haley, proudly boasted of the capacity of the SPHiNX virtual tape appliance to meet and even vastly exceed the kind of stringent compliance requirements needed for the mission-critical data of today’s top financial institutions. Seamless integration with the IBMi environment, as well as fully automated encryption/logging gives financial firms a powerful tool for ensuring they stay online, remain within compliance guidelines, and can perform backup/recovery tasks with both minimal time and cost.
CIO at Foresight, Aaron Patterson, noted how CRDS’s winning product was kicked up as a potential solution through word of mouth from their business partner NASI and how the seamless IBMi environment integration allowed the real-time internet banking operations at Foresight to continue unabated. Patterson, clearly pleased with the exceptionally smooth transition, spoke of how they had SPHiNX up and running in 30 minutes and reminded sector operators of the crucial importance of such a solution, even if they are already using some kind of system to system replication solution (a replicated database that has been corrupted is no good after all).
SPHiNX can easily automate remote backup and the virtual tape at the disaster recovery site provides immediate recovery options. This is the kind of robust solution you want when you are running several banks and dealing with security/compliance issues to boot.
For more information on Crossroads Systems, visit www.Crossroads.com
Today's Top 3
OTC Stock Review
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Consorteum Holdings, Inc. (CSRH) Files Form 10-K Report With the Securities and Exchange Commission
- Cardium Therapeutics, Inc. (CXM) Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease
- DoMark International, Inc. (DOMK) Subsidiary and Infrared/Solar Apple Accessory Leader, SolaWerks™, Launches New Website
- The Guitammer Company Inc. (GTMM) Insiders Acquire An Aggregate Of 156,000 GTMM Shares In Open Market Purchases
- GlobalWise Investments, Inc. (GWIV) Reports Third Quarter 2012 Financial Results and Provides Revised Fiscal 2012 Guidance
- International Stem Cell Corp. (ISCO) Announces Significant Progress Towards Clinical Development
- Loans4Less.com, Inc. (LFLS) Reports Financial Results for the Third Quarter of 2012
- TNI BioTech Inc. (TNIB) Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
- Viaspace, Inc. (VSPC) Board Chairman and CEO Conduct Interview With The Green Baron Report
- VistaGen Therapeutics, Inc. (VSTA) Enhances Predictive Liver Toxicology and Drug Metabolism Bioassay System -- LiverSafe 3D™